Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hypothalamus and obesity.

Peter J King1

  • 1Johnson & Johnson Pharmaceutical Research and Development, A Division of Janssen Pharmaceutica N.V., Metabolic Disorders, Turnhoutseweg 30, B-2340 Beerse, Belgium. pking3@prdbe.jnj.com

Current Drug Targets
|March 22, 2005
PubMed
Summary

Obesity is linked to lifestyle, with brain pathways controlling hunger and fullness. Understanding hypothalamic appetite regulation offers potential drug targets for obesity treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N-SREBP2 Provides a Mechanism for Dynamic Control of Cellular Cholesterol Homeostasis.

Cells·2024
Same author

Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production.

Nature genetics·2023
Same author

Co-Occurrence of Domestic Dogs and Gastropod Molluscs in Public Dog-Walking Spaces and Implications for Infection with <i>Angiostrongylus vasorum</i>: A Preliminary Study.

Animals : an open access journal from MDPI·2021
Same author

Point absorbers in Advanced LIGO.

Applied optics·2021
Same author

An immunomodulatory role for the Mycobacterium tuberculosis Acr protein in the formation of the tuberculous granuloma.

FEBS letters·2020
Same author

Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation.

Scientific reports·2020

Area of Science:

  • Neuroscience
  • Endocrinology
  • Metabolic Research

Background:

  • Obesity is a global epidemic driven by lifestyle factors.
  • Biological mechanisms of hunger and satiety are complex.
  • Leptin discovery revolutionized understanding of hypothalamic control of appetite.

Purpose of the Study:

  • To review hypothalamic mechanisms controlling ingestive behavior.
  • To explore potential pharmacological targets for obesity treatment.

Main Methods:

  • Characterization of hypothalamic peptides (NPY, AGRP, CART, MCH, Orexins, endocannabinoids) in rodent models.
  • Exploration of peripheral peptide hormones (CCK, Ghrelin, PYY(3-36), GLP-1) involved in feeding regulation.
  • Review of long-term regulatory hormones (leptin, insulin).

Main Results:

  • Numerous hypothalamic peptides and peripheral hormones influence appetite.
  • These hormones converge on the hypothalamus to regulate feeding behavior.
  • Leptin and insulin are key long-term regulators of energy balance.

Conclusions:

  • Hypothalamic appetite regulation involves multiple peptide systems.
  • These systems represent potential therapeutic targets for obesity.
  • Pharmacological interventions targeting these pathways may offer new obesity treatments.

Related Experiment Videos